Update on the Phase 4 Confirmatory Study of ADUHELM®

Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 201.22 +1.26 (0.63%)
Previous Close $199.96    52 Week High $333.65 
Open $200.57    52 Week Low $223.02 
Day High $203.45    P/E 25.76 
Day Low $200.17    EPS $7.81 
Volume 263,391